NCT06076538View on ClinicalTrials.gov

PET/MR for Characterization of Renal Masses (RMs)

RecruitingOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
Renal TumorRenal Cell CarcinomaRenal Tumor, Benign
Interventions
DIAGNOSTIC_TEST

2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging

PET/MR scan utilizing FDG Radiopharmaceutical

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Radiological Society of North America

OTHER

lead

University of Texas Southwestern Medical Center

OTHER